GSK plc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GSK plc and other ETFs, options, and stocks.

About GSK

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. 

CEO
Emma N. Walmsley
CEOEmma N. Walmsley
Employees
70,212
Employees70,212
Headquarters
Middlesex, Greater London
HeadquartersMiddlesex, Greater London
Founded
1999
Founded1999
Employees
70,212
Employees70,212

GSK Key Statistics

Market cap
84.44B
Market cap84.44B
Price-Earnings ratio
13.51
Price-Earnings ratio13.51
Dividend yield
3.51%
Dividend yield3.51%
Average volume
2.99M
Average volume2.99M
High today
$41.02
High today$41.02
Low today
$40.89
Low today$40.89
Open price
$41.05
Open price$41.05
Volume
4.51K
Volume4.51K
52 Week high
$43.84
52 Week high$43.84
52 Week low
$33.33
52 Week low$33.33

GSK News

Quartz 15h
There's a new way to see inside a single cancer cell

A team in the U.K. has found a new window into cancer, thanks to a novel imaging technique that allows them to take a detailed look at the fatty cargo inside a...

There's a new way to see inside a single cancer cell
Seeking Alpha 22h
GSK sues Pfizer, BioNTech over COVID-19 vaccines patents

GSK (NYSE:GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA technology for their COVID-19 C...

GSK sues Pfizer, BioNTech over COVID-19 vaccines patents
Reuters 23h
UPDATE 1-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

(Adds Pfizer comment in paragraph 3, context in paragraphs 4-6) By Blake Brittain April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware fe...

UPDATE 1-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Analyst ratings

45%

of 22 ratings
Buy
45.5%
Hold
40.9%
Sell
13.6%

More GSK News

TipRanks 2d
GSK’s Jemperli Awaits FDA Expansion Approval

GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced that the US FDA has granted priority review for the expansion of Jemperli (do...

TipRanks 7d
GSK Executives Reinforce Commitment via Share Purchase - TipRanks.com - TipRanks

GlaxoSmithKline (GSK) has released an update. Top executives at GSK plc, including CEO Emma Walmsley, have acquired additional ordinary shares through the rein...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.